Lansoprazole Crescent Pharma

Lansoprazole, the active ingredient in Lansoprazole Crescent Pharma, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, and Helicobacter pylori infection in adult patients.

GNH USA supplies Lansoprazole Crescent Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards and is distributed under strict regulatory compliance.

Lansoprazole is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑esophageal reflux disease (GERD): reduces acid exposure and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by suppressing gastric acid secretion. - Helicobacter pylori eradication: enhances the effectiveness of combination antibiotic regimens. - Erosive esophagitis: promotes mucosal recovery by maintaining a higher gastric pH.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: watery stools, usually transient. - Abdominal pain: cramping or discomfort. - Nausea: feeling of queasiness. - Flatulence: increased gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Stevens‑Johnson syndrome: skin blistering and mucosal involvement. - Elevated liver enzymes: indication of hepatic stress. - Hypomagnesemia: low magnesium levels causing muscle cramps. - Acute pancreatitis: abdominal pain radiating to the back.

Before initiating therapy, consider the following safety measures.

- Assess renal function: adjust use in severe impairment. - Review concomitant medications: avoid known contraindicated drugs. - Monitor for infection signs: especially if prolonged use is planned. - Use cautiously in elderly patients: increased sensitivity to adverse effects. - Discuss pregnancy and lactation: evaluate risk‑benefit with prescriber. - Store at room temperature: keep in the original container, protect from moisture and light.

Lansoprazole can alter the pharmacokinetics of several drugs; interaction severity varies.

Major Interactions (Avoid): - Ketoconazole: reduced absorption and efficacy. - Atazanavir: decreased plasma concentrations. - Clopidogrel: impaired activation leading to reduced antiplatelet effect. - Warfarin: potential increase in INR and bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum levels, monitor cardiac function. - Methotrexate: higher toxicity risk, especially at high doses. - Phenytoin: decreased levels, may require dosage adjustment.